Accelerate drug development           Proteomics technology           

 Products and Services
Client Services Client Collaborations Technology Access IBI provides integrated resources for companies involved in drug discovery, development and/or diagnostics by providing comprehensive analysis with a commercial platform that is reproducible, flexible, and robust. By teaming with IBI, not only is development time shortened and novel information obtained, but significant savings are realized by eliminating capital equipment purchases, facilities design, and recruitment of skilled personnel.

Currently, IBI products are available through partnerships and contract service collaborations, providing routine as well as custom assay design and data analysis. Contract service builds on a range of opportunities, from sample projects based on a limited, defined scope to collaborations involving broader targets with larger numbers of samples, to full platform integration and Technology Access.

Research alliances and licensing partnerships often include shared objectives and rewards. For platform developers, the integration of standardized sample preparation with direct analysis offers a solution to the use of mass spectrometry as a tool for routine, high throughput analysis.

Regardless of the product or service, all of our clients and partners gain access to a full array of analytical tools and equipment including proprietary Mass Spectrometric Immunoassay (MSIA) and Bioreactive Mass Spectrometer Probes (BRP™), MALDI & Electrospray mass spectrometers, surface plasmon resonance -mass spectrometry , and customized robotics. The technology platforms are complemented by a staff of MASSAY System experts to enable fast assay design with high quality results.

Explore this section
Client Services
Technology Access

Related information
Biomarker discovery
Proteomics technology
Request information

Home | Sitemap | Directions | Literature